Apigenin inhibits renal cell carcinoma cell proliferation

Shuai Meng(Capital Medical University), Liping Xie(First Affiliated Hospital Zhejiang University), Xiao Wang(Qingdao University), Hong Chen(Zhejiang University), Ben Liu(Zhejiang Cancer Hospital), Shiqi Li(University of Science and Technology of China), Zhen Liang(Capital Medical University), Xin Xu(Dalian Medical University), Xiangyi Zheng(Tianjin University), Jiangfeng Li(First Affiliated Hospital Zhejiang University), Yi Zhu(Xuzhou Medical College)
Oncotarget
February 28, 2017
10.18632/oncotarget.15771
Cited by 86

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188